185 related articles for article (PubMed ID: 31870760)
1. Clinical and microbiological characteristics of cryptococcosis at an university hospital in China from 2013 to 2017.
Fang LF; Zhang PP; Wang J; Yang Q; Qu TT
Braz J Infect Dis; 2020; 24(1):7-12. PubMed ID: 31870760
[TBL] [Abstract][Full Text] [Related]
2. High Prevalence of HIV-Related Cryptococcosis and Increased Resistance to Fluconazole of the
Yang C; Bian Z; Blechert O; Deng F; Chen H; Li Y; Yang Y; Chen M; Zhan P
Front Cell Infect Microbiol; 2021; 11():723251. PubMed ID: 34790585
[TBL] [Abstract][Full Text] [Related]
3. Molecular epidemiology and in vitro antifungal susceptibility testing of 108 clinical Cryptococcus neoformans sensu lato and Cryptococcus gattii sensu lato isolates from Denmark.
Hagen F; Hare Jensen R; Meis JF; Arendrup MC
Mycoses; 2016 Sep; 59(9):576-84. PubMed ID: 27061834
[TBL] [Abstract][Full Text] [Related]
4. Molecular types of Cryptococcus neoformans and Cryptococcus gattii in Western Australia and correlation with antifungal susceptibility.
Lee GA; Arthur I; Merritt A; Leung M
Med Mycol; 2019 Nov; 57(8):1004-1010. PubMed ID: 30649538
[TBL] [Abstract][Full Text] [Related]
5. Predominance of Cryptococcus neoformans var. grubii multilocus sequence type 5 and emergence of isolates with non-wild-type minimum inhibitory concentrations to fluconazole: a multi-centre study in China.
Fan X; Xiao M; Chen S; Kong F; Dou HT; Wang H; Xiao YL; Kang M; Sun ZY; Hu ZD; Wan Z; Chen SL; Liao K; Chu YZ; Hu TS; Zou GL; Hou X; Zhang L; Zhao YP; Xu YC; Liu ZY
Clin Microbiol Infect; 2016 Oct; 22(10):887.e1-887.e9. PubMed ID: 27432767
[TBL] [Abstract][Full Text] [Related]
6. Molecular typing, in vitro susceptibility and virulence of Cryptococcus neoformans/Cryptococcus gattii species complex clinical isolates from south-eastern Brazil.
Grizante Barião PH; Tonani L; Cocio TA; Martinez R; Nascimento É; von Zeska Kress MR
Mycoses; 2020 Dec; 63(12):1341-1351. PubMed ID: 32869413
[TBL] [Abstract][Full Text] [Related]
7. Molecular epidemiology of Cryptococcus neoformans and Cryptococcus gattii in China between 2007 and 2013 using multilocus sequence typing and the DiversiLab system.
Dou HT; Xu YC; Wang HZ; Li TS
Eur J Clin Microbiol Infect Dis; 2015 Apr; 34(4):753-62. PubMed ID: 25471194
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterisation of clinical Cryptococcus neoformans and Cryptococcus gattii isolates from Sichuan province, China.
Wu SY; Lei Y; Kang M; Xiao YL; Chen ZX
Mycoses; 2015 May; 58(5):280-7. PubMed ID: 25808662
[TBL] [Abstract][Full Text] [Related]
9. Microbiological, epidemiological, and clinical characteristics and outcomes of patients with cryptococcosis in Taiwan, 1997-2010.
Tseng HK; Liu CP; Ho MW; Lu PL; Lo HJ; Lin YH; Cho WL; Chen YC;
PLoS One; 2013; 8(4):e61921. PubMed ID: 23613973
[TBL] [Abstract][Full Text] [Related]
10. Molecular epidemiology and antifungal susceptibilities of Cryptococcus species isolates from HIV and non-HIV patients in Southwest China.
Wu SY; Kang M; Liu Y; Chen ZX; Xiao YL; He C; Ma Y
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):287-295. PubMed ID: 32895755
[TBL] [Abstract][Full Text] [Related]
11. Molecular epidemiology and antifungal susceptibility profiles of clinical
Bandalizadeh Z; Shokohi T; Badali H; Abastabar M; Babamahmoudi F; Davoodi L; Mardani M; Javanian M; Cheraghmakani H; Sepidgar AA; Badiee P; Khodavaisy S; Afshari SAK; Ahmadikia K; Seyedmousavi S
J Med Microbiol; 2020 Jan; 69(1):72-81. PubMed ID: 31750814
[No Abstract] [Full Text] [Related]
12. Microbiological characteristics of clinical isolates of Cryptococcus spp. in Bahia, Brazil: molecular types and antifungal susceptibilities.
Matos CS; de Souza Andrade A; Oliveira NS; Barros TF
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1647-52. PubMed ID: 22278291
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibility of the yeast pathogen cryptococcus to fluconazole and other azoles varies with molecular genotype.
Chong HS; Dagg R; Malik R; Chen S; Carter D
J Clin Microbiol; 2010 Nov; 48(11):4115-20. PubMed ID: 20844209
[TBL] [Abstract][Full Text] [Related]
14. Genotypic diversity and antifungal susceptibility of Cryptococcus neoformans isolates from paediatric patients in China.
Hong N; Chen M; Xu N; Al-Hatmi AMS; Zhang C; Pan WH; Hagen F; Boekhout T; Xu J; Zou XB; Liao WQ
Mycoses; 2019 Feb; 62(2):171-180. PubMed ID: 30341799
[TBL] [Abstract][Full Text] [Related]
15. Microbiological and clinical characteristics of cryptococcemia: a retrospective analysis of 85 cases in a Chinese hospital.
Fu Y; Xu M; Zhou H; Yao Y; Zhou J; Pan Z
Med Mycol; 2020 Jun; 58(4):478-484. PubMed ID: 31504739
[TBL] [Abstract][Full Text] [Related]
16. Molecular epidemiology reveals genetic diversity among 363 isolates of the Cryptococcus neoformans and Cryptococcus gattii species complex in 61 Ivorian HIV-positive patients.
Kassi FK; Drakulovski P; Bellet V; Krasteva D; Gatchitch F; Doumbia A; Kouakou GA; Delaporte E; Reynes J; Mallié M; Menan HIE; Bertout S
Mycoses; 2016 Dec; 59(12):811-817. PubMed ID: 27461533
[TBL] [Abstract][Full Text] [Related]
17. Cryptococcal meningitis in non-HIV patients in the State of Amazonas, Northern Brazil.
Pinheiro SB; Sousa ES; Cortez ACA; da Silva Rocha DF; Menescal LSF; Chagas VS; Gómez ASP; Cruz KS; Santos LO; Alves MJ; Matsuura ABJ; Wanke B; Trilles L; Frickmann H; de Souza JVB
Braz J Microbiol; 2021 Mar; 52(1):279-288. PubMed ID: 33025379
[TBL] [Abstract][Full Text] [Related]
18. Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico.
González GM; Casillas-Vega N; Garza-González E; Hernández-Bello R; Rivera G; Rodríguez JA; Bocanegra-Garcia V
Folia Microbiol (Praha); 2016 Jan; 61(1):51-6. PubMed ID: 26109075
[TBL] [Abstract][Full Text] [Related]
19. Molecular epidemiology reveals genetic diversity amongst isolates of the Cryptococcus neoformans/C. gattii species complex in Thailand.
Kaocharoen S; Ngamskulrungroj P; Firacative C; Trilles L; Piyabongkarn D; Banlunara W; Poonwan N; Chaiprasert A; Meyer W; Chindamporn A
PLoS Negl Trop Dis; 2013; 7(7):e2297. PubMed ID: 23861989
[TBL] [Abstract][Full Text] [Related]
20. Antifungal susceptibility testing with YeastONE™ is not predictive of clinical outcomes of Cryptococcus neoformans var. grubii fungemia.
Yang JH; Huang PY; Cheng CW; Shie SS; Lin ZF; Yang LY; Lee CH; Wu TS
Med Mycol; 2021 Nov; 59(11):1114-1121. PubMed ID: 34374784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]